Results 11 to 20 of about 26,031 (166)

Japanese encephalitis virus infection in an endemic area: hospital based study 1998 to 2000

Sri Lankan Journal of Infectious Diseases, 2012
Gampaha Deputy Provincial Director of Health Services division reported a large number of Japanese encephalitis cases during 1996 to 1997. Notified cases included unconfirmed and confirmed cases.
HAKM Gunasekera, CP Senanayake, L Mendis, NP Sunil Chandra   +3 more
doaj   +1 more source

Japanese Encephalitis Vaccines [PDF]

Current Treatment Options in Infectious Diseases, 2020
As an eminently vaccine-preventable disease, encephalitis caused by Japanese encephalitis virus (JEV) has attracted an unusually high degree of attention from those seeking to develop viral vaccines. Since the 1950s, all types of JEV vaccines including inactivated, recombinant and live attenuated ones have been licensed.
openaire   +2 more sources

The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine

Tropical Diseases, Travel Medicine and Vaccines, 2017
The epidemiology of Japanese Encephalitis and risk to the traveler has changed and continues to evolve. The spread of Japanese Encephalitis virus into new environments, changes in agricultural practice and animal vectors, climate change, peri-urban ...
Bradley Connor, William B. Bunn
doaj   +1 more source

A mouse model of peripheral nerve injury induced by Japanese encephalitis virus.

PLoS Neglected Tropical Diseases, 2022
Japanese encephalitis virus (JEV) is the most important cause of acute encephalitis in Eastern/Southern Asia. Infection with this virus also induces peripheral nerve injury. However, the disease pathogenesis is still not completely understood.
Xiaoli Wang, Guowei Wang, Huan Yang, Shihong Fu, Ying He, Fan Li, Huanyu Wang, Zhenhai Wang   +7 more
doaj   +1 more source

Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.

BMC Microbiology, 2002
Background In Southeast Asia, dengue viruses often co-circulate with other flaviviruses such as Japanese encephalitis virus, and due to the presence of shared antigenic epitopes it is often difficult to use serological methods to distinguish between ...
Sum Magdline, Wang Seok, Cardosa Mary, Tio Phaik   +3 more
doaj   +1 more source

Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization

International Journal of Infectious Diseases, 2021
Background: Findings were published in 2015 that highlighted the endemicity of Japanese Encephalitis (JE) in the Philippines. The policymakers responded by conducting an immunization campaign and strengthening the surveillance system.
Anna Lena Lopez, Peter Francis Raguindin, Josephine G. Aldaba, Ferchito Avelino, Ava Kristy Sy, James D. Heffelfinger, Maria Wilda T. Silva   +6 more
doaj   +1 more source

The First Case of Bacillus Calmette-Guérin-Induced Autoimmune Encephalitis. [PDF]

IJU Case Rep
ABSTRACT Introduction Intravesical bacillus Calmette‐Guerin (BCG) therapy is a standard treatment for intermediate to high‐risk non‐muscle invasive bladder cancer. While local side effects are common, systemic complications are rare and can be serious.
Ishii M, Honda H, Machiya S, Horitani H, Horii S, Kobayashi M, Ono Y.   +6 more
europepmc   +2 more sources

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children

Human Vaccines & Immunotherapeutics, 2022
Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai ...
Weerawan Hattasingh, Pornthep Chanthavanich, Chukiat Sirivichayakul, Watcharee Arunsodsai, Surachai Surangsrirat, Termsang Srisuwannaporn, Benjawan Kaewma, Sutee Yoksan, Kriengsak Limkittikul, Junwei Yang, Yu Mao   +10 more
doaj   +1 more source

Japanese Encephalitis Vaccines

Journal of Bioterrorism & Biodefense, 2011
Japanese encephalitis (JE) is a significant human health concern in Asia, Indonesia and parts of Australia with more than 3 billion people potentially at risk of infection with Japanese encephalitis virus (JEV), the causative agent of JE. Given the risk to human health and the theoretical potential for JEV use as a bioweapon, the development of safe ...
Monica A, McArthur, Michael R, Holbrook
openaire   +2 more sources

The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus

Frontiers in Cellular and Infection Microbiology, 2023
The Japanese encephalitis virus (JEV) is classified into five distinct genotypes, with genotypes 1 and 3 historically showing higher activity. These genotypes are the primary agents of viral encephalitis in the Asian continent.
Weijia Zhang, Qikai Yin, Huanyu Wang, Guodong Liang   +3 more
doaj   +1 more source